云开亚美 is a digital medical services platform that delivers end-to-end management for chronic and specialty diseases via an integrated “teach–med–manage–drug–insurance” model. Since its 2011 founding the company has built an online pharmacy, pharmacist follow-up services, and an internet hospital (Hainan internet hospital launched in 2020) alongside offline care centers and specialty insurance products. It operates disease-specific verticals covering rheumatology/orthopedics, neurology, oncology and others, and reports precise coverage of millions of chronic/special-disease patients and access to thousands of top-tier (3A) specialists. The company says these assets have driven high-growth revenue and industry-leading profitability and enabled strategic partnerships with major domestic and international pharma firms. Product and service offerings include a 7S clinical-pathway methodology, one-to-one pharmacist/medical follow-up, disease-focused offline care and patient support centers, and tailored insurance (e.g., the "肠复宝" colorectal-cancer insurance). Cloud investments and product roadmaps emphasize expanding multi-specialty vertical ecosystems and developing digital therapeutics and AI tools to improve treatment efficiency and outcomes.

Total raised

$31M

Funding rounds

1

Latest round

Series C

Latest activity

Dec 2021